Strides Pharma Science Ltd
₹893.95
(2.41%)
Thu, 12 Mar 2026, 02:33 am
Strides Pharma Science Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 27.86 | 27.86 | 28.30 | 28.30 | 26.82 |
| FII | 29.52 | 28.51 | 28.02 | 28.32 | 28.48 |
| DII | 13.02 | 12.98 | 13.30 | 13.72 | 16.92 |
| Public | 29.59 | 30.64 | 30.37 | 29.65 | 27.77 |
| Government | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Strides Pharma Science Ltd Shareholding Pattern
The Strides Pharma Science Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Strides Pharma Science Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Strides Pharma Science Ltd (NSE: STAR, BSE: 532531) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Strides Pharma Science Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Strides Pharma Science Ltd Shareholding Pattern (Latest)
The latest Strides Pharma Science Ltd shareholding for Dec 2025 is:
- Promoters: 27.86%
- FII: 29.52%
- DII: 13.02%
- Public: 29.59%
- Government: 0.01%
Promoter holding in Strides Pharma Science Ltd remains stable, reflecting consistent long-term commitment.
Strides Pharma Science Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Strides Pharma Science Ltd.
- Dec 2025: 27.86%
- Sept 2025: 27.86%
- Jun 2025: 28.30%
- Mar 2025: 28.30%
- Dec 2024: 26.82%
Promoter stake remains largely stable, showing consistent ownership structure.
Strides Pharma Science Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Strides Pharma Science Ltd.
- Dec 2025: 29.52%
- Sept 2025: 28.51%
- Jun 2025: 28.02%
- Mar 2025: 28.32%
- Dec 2024: 28.48%
FII holding in Strides Pharma Science Ltd has increased recently, indicating rising foreign investor interest.
Strides Pharma Science Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Dec 2025: 13.02%
- Sept 2025: 12.98%
- Jun 2025: 13.30%
- Mar 2025: 13.72%
- Dec 2024: 16.92%
DII stake in Strides Pharma Science Ltd has increased over time, indicating growing domestic institutional confidence.
Strides Pharma Science Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Dec 2025: 29.59%
- Sept 2025: 30.64%
- Jun 2025: 30.37%
- Mar 2025: 29.65%
- Dec 2024: 27.77%
Public holding remains stable with consistent retail participation.
Strides Pharma Science Ltd Government Holding
Government holding in Strides Pharma Science Ltd currently stands at 0.01%.
Government presence indicates institutional backing and regulatory confidence.
Strides Pharma Science Ltd Shareholding Analysis Summary
The Strides Pharma Science Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Strides Pharma Science Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Strides Pharma Science Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800